The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ADAGENE ADS 005329107   7,526,855 3,782,339 SH   SOLE   3,782,339 0 0
AKERO THERAPEUTICS COM 00973Y108   272,249,798 5,733,989 SH   SOLE   5,733,989 0 0
ALIGNMENT HEALTHCARE COM 01625V104   423,812,111 24,287,227 SH   SOLE   24,287,227 0 0
ALKAMI COM 01644J108   297,868,363 11,991,480 SH   SOLE   11,991,480 0 0
ALUMIS COM 022307102   5,177,145 1,297,530 SH   SOLE   1,297,530 0 0
CENTESSA PHARMACEUTICALS SPONSERED ADS 152309100   234,784,087 9,681,818 SH   SOLE   9,681,818 0 0
CHIME COM SHS CL A 16935C109   387,440,689 19,208,760 SH   SOLE   19,208,760 0 0
DLOCAL CLASS A COM G29018101   666,257,605 46,656,695 SH   SOLE   46,656,695 0 0
EUROPEAN WAX CENTER CLASS A COM 29882P106   52,310,863 13,110,492 SH   SOLE   13,110,492 0 0
GROVE COLLABORATIVE COM CL A 39957D201   3,712,289 2,474,859 SH   SOLE   2,474,859 0 0
PHARVARIS COM N69605108   200,379,737 8,031,252 SH   SOLE   8,031,252 0 0
REVOLUTION MEDICINES COM 76155X100   115,555,788 2,474,428 SH   SOLE   2,474,428 0 0
RISKIFIED SHS CL A M8216R109   24,920,991 5,324,998 SH   SOLE   5,324,998 0 0
ROYALTY PHARMA CL A G7709Q104   52,920,000 1,500,000 SH   SOLE   1,500,000 0 0
WEBULL ORD SHS G9572D103   106,471,243 7,198,867 SH   SOLE   7,198,867 0 0
XP, INC CL A G98239109   479,478,203 25,517,733 SH   SOLE   25,517,733 0 0